JANE STREET GROUP, LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$40,758
-54.7%
12,898
-44.6%
0.00%
Q2 2023$90,020
-2.8%
23,261
-30.5%
0.00%
Q1 2023$92,656
+172.5%
33,450
+168.5%
0.00%
Q2 2022$34,000
-72.8%
12,459
-56.9%
0.00%
Q1 2022$125,000
+92.3%
28,899
+132.3%
0.00%
Q4 2021$65,000
-62.2%
12,443
-55.5%
0.00%
Q3 2021$172,000
-90.2%
27,959
-83.9%
0.00%
-100.0%
Q2 2021$1,754,000173,7020.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders